Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Dose-Finding Study of JTT-305 in Primary Osteoporosis
jRCT2080220803Phase 2
- Sponsor
- Japan Tobacco
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in involutional osteoporosis comparing JTT-305 with Placebo (2 arms).
02
Drugs
encaleret
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCT2080220803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220803.